GOSS Stock Analysis: Buy, Sell, or Hold?

GOSS - Gossamer Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.16
0.00 (-2.26%) ▼
5d: +1.42%
30d: -23.73%
90d: -61.13%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 04, 2026

Get Alerted When GOSS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: GOSS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GOSS is currently trading at $0.16, which is considered slightly low relative to its 30-day fair value range of $0.15 to $0.24.

Technical Outlook: Technically, GOSS is in a strong uptrend. Immediate support is located at $0.14, while resistance sits at $0.20.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.46 (+2613.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $0.15 - $0.24
Company Quality Score 50/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 2613.8% below Wall St target ($4.46)

Trading Range Analysis

30-Day Trading Range $0.15 - $0.24
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $0.14
Resistance Level $0.20
Current Trend Strong Uptrend
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.50
Wall Street Target $4.46 (+2613.8%)
Revenue Growth (YoY) 71.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 22, 2026 11:11 PM ET
Data refreshes hourly during market hours. Next update: 12:11 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for GOSS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 53 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 64 BUY
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 56 HOLD
DYN
Dyne Therapeutics Inc
STRONG BUY
14 analysts
$38 60 BUY
DNTH
Dianthus Therapeutics In…
STRONG BUY
12 analysts
$128 57 HOLD

Advanced GOSS Option Strategies

Professional options setups generated by AI based on today's GOSS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for GOSS

GOSS Technical Chart GOSS Price Prediction GOSS Earnings Date GOSS Investment Advisor GOSS Fair Price Analyzer GOSS Options Advisor GOSS Options Chain GOSS Options Analysis GOSS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals